For individuals living with Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a serious condition, the introduction of this treatment and the formulated version represents a genuine change. These groundbreaking therapies stabilize the transthyretin protein, slowing its damaging build-up and reducing the impact of the condition . People are now exp… Read More